Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia

To determine cost-utility of interferons intramuscular beta-1-a (IFNβ-1a-IM), subcutaneous beta-1-a (IFNβ-1a-SC), subcutaneous beta-1-b (IFNβ-1b-SC) in patients with Relapsing-Remitting Multiple Sclerosis (RRMS) in Colombia.

Source: Value in Health - April 30, 2016 Category: Global & Universal Authors: J Ordoñez, A Delgado Source Type: research